Literature DB >> 22464688

Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure-activity study.

Erik Chorell1, Jerome S Pinkner, Christoffer Bengtsson, Thomas Sainte-Luce Banchelin, Sofie Edvinsson, Anna Linusson, Scott J Hultgren, Fredrik Almqvist.   

Abstract

Pilicides prevent pili formation and thereby the development of bacterial biofilms in Escherichia coli. We have performed a comprehensive structure activity relationship (SAR) study of the dihydrothiazolo ring-fused 2-pyridone pilicide central fragment by varying all open positions. Orthogonal projections to latent structures discriminant analysis (OPLS-DA) was used to distinguish active from inactive compounds in which polarity proved to be the most important factor for discrimination. A quantitative SAR (QSAR) partial least squares (PLS) model was calculated on the active compounds for prediction of biofilm inhibition activity. In this model, compounds with high inhibitory activity were generally larger, more lipophilic, more flexible and had a lower HOMO. Overall, this resulted in both highly valuable SAR information and potent inhibitors of type 1 pili dependent biofilm formation. The most potent biofilm inhibitor had an EC(50) of 400 nM.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464688      PMCID: PMC3753005          DOI: 10.1016/j.bmc.2012.01.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  25 in total

1.  Biofilm resistance to antimicrobial agents.

Authors:  Karen D Xu; Gordon A McFeters; Philip S Stewart
Journal:  Microbiology       Date:  2000-03       Impact factor: 2.777

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 3.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

4.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

5.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli.

Authors:  Veronica Aberg; Mattias Hedenström; Jerome S Pinkner; S J Hultgren; Fredrik Almqvist
Journal:  Org Biomol Chem       Date:  2005-09-05       Impact factor: 3.876

7.  An enantioselective ketene-imine cycloaddition method for synthesis of substituted ring-fused 2-pyridinones.

Authors:  H Emtenäs; L Alderin; F Almqvist
Journal:  J Org Chem       Date:  2001-10-05       Impact factor: 4.354

8.  Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli.

Authors:  Veronica Berg; Pralay Das; Erik Chorell; Mattias Hedenström; Jerome S Pinkner; Scott J Hultgren; Fredrik Almqvist
Journal:  Bioorg Med Chem Lett       Date:  2008-05-07       Impact factor: 2.823

9.  Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.

Authors:  Lynette Cegelski; Jerome S Pinkner; Neal D Hammer; Corinne K Cusumano; Chia S Hung; Erik Chorell; Veronica Aberg; Jennifer N Walker; Patrick C Seed; Fredrik Almqvist; Matthew R Chapman; Scott J Hultgren
Journal:  Nat Chem Biol       Date:  2009-10-25       Impact factor: 15.040

10.  Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria.

Authors:  Jerome S Pinkner; Han Remaut; Floris Buelens; Eric Miller; Veronica Aberg; Nils Pemberton; Mattias Hedenström; Andreas Larsson; Patrick Seed; Gabriel Waksman; Scott J Hultgren; Fredrik Almqvist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-10       Impact factor: 11.205

View more
  16 in total

1.  Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.

Authors:  Bryan D Yestrepsky; Yuanxi Xu; Meghan E Breen; Xiaoqin Li; Walajapet G Rajeswaran; Jenny G Ryu; Roderick J Sorenson; Yasuhiro Tsume; Michael W Wilson; Wenpeng Zhang; Duxin Sun; Hongmin Sun; Scott D Larsen
Journal:  Bioorg Med Chem       Date:  2013-02-01       Impact factor: 3.641

Review 2.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 3.  Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella.

Authors:  Glenn T Werneburg; David G Thanassi
Journal:  EcoSal Plus       Date:  2018-03

Review 4.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Current Research Approaches to Target Biofilm Infections.

Authors:  Erik van Tilburg Bernardes; Shawn Lewenza; Shauna Reckseidler-Zenteno
Journal:  Postdoc J       Date:  2015-06

Review 6.  Therapeutic Approaches Targeting the Assembly and Function of Chaperone-Usher Pili.

Authors:  John J Psonis; David G Thanassi
Journal:  EcoSal Plus       Date:  2019-03

Review 7.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

Review 8.  Urinary tract infections: current and emerging management strategies.

Authors:  Amelia E Barber; J Paul Norton; Adam M Spivak; Matthew A Mulvey
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

9.  Asymmetric synthesis of 2,4,5-trisubstituted Δ2-thiazolines.

Authors:  Christoffer Bengtsson; Hanna Nelander; Fredrik Almqvist
Journal:  Chemistry       Date:  2013-06-17       Impact factor: 5.236

10.  Prospects for Anti-Biofilm Pharmaceuticals.

Authors:  Philip S Stewart
Journal:  Pharmaceuticals (Basel)       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.